Task: Answer the multiple-choice question.
Question: Which compound exhibits a -26.205\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a: CCOC(=O)c1ccccc1NC(=O)CSc1nc(N)cc(=O)[nH]1
b: c1ccc(C2=NOC(c3nnc(-c4ccccc4)o3)C2)cc1
Answer: b. c1ccc(C2=NOC(c3nnc(-c4ccccc4)o3)C2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
c1ccc(C2=NOC(c3nnc(-c4ccccc4)o3)C2)cc1
c1ccc(C2=NOC(c3nnc(-c4ccccc4)o3)C2)cc1
2-phenyl-5-(3-phenyl-4,5-dihydro-1,2-oxazol-5-yl)-1,3,4-oxadiazole